7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 
      
    		                  
      operating activities
    		                  
      net income
    		33,503,000 43,262,000 16,746,000 -126,903,000 -141,354,000 25,698,000 2,165,000 23,086,000 23,214,000 -9,110,000 38,373,000 -2,777,000 -22,054,000 -27,721,000 -25,552,000 -17,000 2,887,000 -9,772,000 
      adjustments to reconcile net income to cash from operating activities:
    		                  
      goodwill impairment
    		   74,000,000               
      benefit from bad debts
    		-909,000 239,000 1,671,000  1,719,000 800,000 896,000            
      deferred tax expense
    		  1,024,000      -532,000  -10,944,000        
      depreciation and amortization
    		7,735,000 6,256,000 5,932,000 9,206,000 9,559,000 9,331,000 10,125,000 9,950,000 2,626,000 29,852,000 23,628,000 24,556,000 23,023,000 6,492,000 6,490,000 6,483,000 6,481,000 6,887,000 
      amortization of developed technology and backlog
    		                  
      amortization of debt discount and issuance costs
    		950,000 1,951,000 1,506,000 1,435,000 1,551,000 1,548,000 1,553,000 1,447,000 4,125,000 1,854,000 1,717,000 1,576,000 1,710,000 1,383,000 8,535,000 1,532,000 3,586,000 1,206,000 
      gain on extinguishment of debts
    		0                  
      equity-based compensation
    		4,647,000 3,898,000 2,798,000 3,498,000 2,015,000 910,000 3,926,000 2,845,000 3,384,000 3,305,000 4,205,000 2,964,000 4,508,000 2,051,000 2,239,000 1,556,000 7,911,000  
      change in fair value of contingent consideration
    		  -150,000 396,000 -39,000              
      warranty provision
    		4,954,000 3,616,000 1,720,000 3,127,000 97,000 1,077,000 -1,138,000 4,215,000 -28,000 -189,000 3,126,000 621,000 594,000 211,000 -120,000 123,000 302,000 320,000 
      inventory reserve
    		678,000 1,843,000 839,000                
      other non-cash
    		                  
      changes in working capital
    		-34,610,000 -5,547,000 -48,784,000                
      net cash from operating activities
    		27,363,000 43,841,000 -13,059,000 57,586,000 44,935,000 3,957,000 47,502,000 93,981,000 71,618,000   -10,667,000 -50,097,000 -97,350,000 -31,728,000 -91,961,000 -42,148,000 104,295,000 
      capex
    		-5,513,000 -6,631,000 -2,352,000 -1,701,000 -1,077,000 -2,131,000 -2,396,000 -5,374,000 -2,191,000   -1,538,000 -2,357,000 -1,105,000 -1,052,000 -630,000 -570,000 -728,000 
      free cash flows
    		21,850,000 37,210,000 -15,411,000 55,885,000 43,858,000 1,826,000 45,106,000 88,607,000 69,427,000   -12,205,000 -52,454,000 -98,455,000 -32,780,000 -92,591,000 -42,718,000 103,567,000 
      investing activities
    		                  
      purchase of property, plant and equipment
    		-5,513,000 -6,631,000 -2,352,000 -1,701,000 -1,077,000 -2,131,000 -2,396,000 -5,374,000 -2,191,000 -3,929,000 -2,795,000 -1,538,000 -2,357,000 -1,105,000 -1,052,000 -630,000 -570,000 -728,000 
      acquisition, net of cash acquired
    		                  
      retirement/disposal of property, plant and equipment
    		   -4,000 -1,000 29,000 10,000            
      sale of equity investment
    		   0               
      net cash from investing activities
    		-170,429,000 -6,631,000 -2,352,000 -15,981,000 10,897,000 -2,102,000 -2,386,000 -5,206,000 -2,191,000 -3,931,000 -2,793,000 -1,540,000 -376,173,000 -1,105,000 -1,052,000 -2,605,000 -10,570,000 -728,000 
      financing activities
    		                  
      proceeds from issuance of other debt
    		51,595,000 49,202,000 7,862,000 74,035,000 6,340,000 10,401,000 2,283,000 2,795,000 36,715,000 -19,031,000 8,620,000 24,370,000 6,229,000      
      proceeds from issuance of convertible notes
    		0                  
      premium paid on capped call
    		0                  
      fees paid on issuance of convertible notes
    		0                  
      repayments of other debt
    		-64,427,000                  
      repayments of term loan facility
    		0                  
      repayments of convertible notes
    		0                  
      contingent consideration payments
    		0 0 -1,204,000 0 0 0 -1,427,000 0 0          
      other financing
    		90,000 -1,109,000 -14,000                
      net cash from financing activities
    		-12,742,000 -11,051,000 -1,725,000 397,000 -8,097,000 431,000 -4,575,000 -17,319,000 -45,128,000 -24,706,000 -89,551,000 21,961,000 100,736,000 349,734,000 131,489,000 93,115,000 -36,590,000 -22,270,000 
      effect of exchange rate changes on cash and cash equivalent balances
    		141,000 3,118,000 2,488,000 -10,233,000 2,317,000 -7,586,000 -2,001,000 3,614,000 -6,255,000 2,290,000 -711,000 -8,199,000 7,355,000      
      net change in cash and cash equivalents and restricted cash
    		-155,667,000 29,277,000 -14,648,000                
      deferred tax benefit
    		   -30,371,000 -3,778,000        6,649,000  -7,889,000 1,429,000 -71,000  
      amortization of developed technology
    		 3,640,000 3,639,000 3,640,000 3,639,000 3,640,000 3,639,000 3,640,000           
      loss on disposal of fixed assets
    		                  
      cash and cash equivalents, and restricted cash beginning of period
    		 0 364,141,000                
      cash and cash equivalents and restricted cash, end of period
    		 29,277,000 349,493,000                
      principal payments on other debt
    		  -7,294,000 -72,545,000 -12,208,000 -8,890,000 -3,781,000 -19,039,000 -30,767,000          
      principal payments on term loan facility
    		  -1,075,000 -1,075,000 -1,075,000 -1,080,000 -1,070,000 -1,075,000 -51,075,000     -1,075,000 -101,075,000 -1,075,000 -30,000,000  
      operating activities:
    		                  
      adjustments to net income
    		                  
      impairment of long-lived assets
    		                  
      allowance for credit losses
    		                  
      gain on debt refinancing
    		                  
      write-down of inventories
    		   442,000 1,254,000 627,000 600,000 1,844,000 1,129,000          
      changes in operating assets and liabilities, net of business acquisition:
    		                  
      accounts receivable
    		   -442,000 43,244,000 -97,369,000 95,990,000 99,164,000 74,675,000 62,052,000 -27,424,000 -67,344,000 -44,268,000 -58,654,000 -23,829,000 -31,673,000 -2,692,000 -698,000 
      inventories
    		   -14,823,000 -22,757,000 4,335,000 -11,542,000 54,189,000 -10,290,000 35,143,000 62,918,000 -30,941,000 -46,250,000 -32,863,000 -34,878,000 -14,197,000 -6,246,000 -20,652,000 
      income tax receivables
    		   33,000 -2,832,000 -1,315,000 2,000 -3,156,000 -55,000 9,221,000 3,452,000 14,862,000 -21,924,000 -2,599,000 3,204,000 -5,502,000 13,003,000 -640,000 
      prepaid expenses and other
    		   -24,505,000 -41,750,000 -1,234,000 -2,219,000 -8,700,000 1,152,000 7,978,000 11,522,000 -6,336,000 5,960,000 -15,456,000 -6,596,000 4,042,000 -3,216,000 -6,121,000 
      accounts payable
    		   24,475,000 36,637,000 20,959,000 -23,891,000 -52,097,000 -16,099,000 -29,538,000 -32,440,000 15,094,000 59,551,000 6,689,000 3,326,000 9,178,000 -10,556,000 31,765,000 
      accrued expenses and other
    		   34,492,000 -19,756,000 35,397,000 -50,569,000 -13,159,000 11,387,000 -40,247,000 37,915,000 -3,671,000 7,027,000 7,450,000 12,224,000 -15,675,000 5,134,000 6,269,000 
      income tax payable
    		   3,790,000 -1,969,000 -3,619,000 935,000 2,674,000 -10,568,000 -3,706,000 7,553,000 4,158,000 -8,760,000 -569,000 629,000 -10,224,000 1,410,000 286,000 
      lease liabilities
    		   -2,894,000 -2,595,000 -663,000 -2,472,000 9,227,000 -9,464,000 1,870,000 -2,786,000 -1,385,000 6,085,000 -116,000 269,000 -179,000 247,000  
      deferred revenue
    		   8,443,000 20,050,000 6,820,000 20,250,000 -33,821,000 -14,053,000 24,230,000 -12,491,000 65,902,000 -18,639,000 17,855,000 29,889,000 -38,422,000 -59,941,000 105,040,000 
      investing activities:
    		                  
      cash payments for the acquisition of right-of-use assets
    		                  
      acquisition of sti, net of cash acquired
    		         -2,000 2,000 -2,000 -373,816,000      
      safe investment
    		                  
      financing activities:
    		                  
      proceeds from series a issuance
    		         0 0 0 33,098,000 0     
      proceeds from common stock issuance
    		         0 0 0 15,885,000 0     
      series a equity issuance costs
    		        -1,000 -726,000 -592,000 -400,000 -175,000 0     
      tax withholding related to vesting of equity-based compensation
    		   -18,000 -1,154,000 0 -580,000            
      common stock issuance costs
    		         0 0 0 -450,000 0     
      dividends paid on series a preferred
    		         0         
      payments on revolving credit facility
    		         0 -83,000,000   -24,033,000     
      proceeds from revolving credit facility
    		         0 15,000,000 49,000,000 52,000,000 24,033,000 0    
      net change in cash and cash equivalents
    		   31,769,000 50,052,000 -5,300,000 38,540,000 75,070,000 18,044,000 71,123,000 11,732,000 1,555,000 -318,179,000 251,279,000     
      cash and cash equivalents and restricted cash, beginning of period
    		                  
      supplemental cash flow information
    		                  
      cash paid for interest
    		   8,989,000    7,813,000 20,256,000          
      cash paid for income taxes
    		   2,746,000    9,145,000 18,313,000          
      non-cash investing and financing activities
    		                  
      dividends accrued on series a preferred
    		   7,246,000    6,803,000 6,696,000          
      stock consideration paid for acquisition of sti
    		         0 0 0 200,224,000      
      adjustments to net income:
    		                  
      cash and cash equivalents, beginning of period
    		    0 0 249,080,000 0 0 0 0 0 367,670,000 0     
      cash and cash equivalents, end of period
    		       75,070,000 18,044,000 71,123,000 11,732,000 1,555,000 49,491,000 251,279,000     
      deferred tax (benefit) expense
    		      -13,000           927,000 
      contingent consideration gain
    		      -735,000            
      benefit from (recovery of) bad debts
    		       2,644,000  1,939,000 150,000 365,000 145,000 107,000 -23,000 -16,000 -535,000 102,000 
      contingent consideration
    		       732,000 189,000 1,474,000 -572,000 -1,678,000 -3,731,000 1,625,000 936,000 -13,000 148,000 10,433,000 
      retirement/disposal of pp&e
    		                  
      investment in equity securities
    		                  
      series a equity issuance costs and commitment fees
    		                  
      debt issuance costs
    		             0 0 0 -6,590,000  
      change in fair value of derivative assets
    		        -116,000          
      warranty payments
    		                  
      dividends on series a preferred
    		                  
      interest paid-in-kind
    		                 0 
      benefit from inventory obsolescence
    		         1,474,000 -2,742,000 0 409,000 336,000 -582,000   -1,292,000 
      changes in operating assets and liabilities, net of acquisition
    		                  
      investment in equity security
    		             0 0 -1,975,000 -10,000,000  
      proceeds from term loan facility
    		                  
      payments on related party loans
    		                 0 
      payment of special distribution
    		                  
      deferred offering costs
    		                 -2,689,000 
      cash flows from operating activities
    		                  
      adjustments to reconcile net income to net cash provided by, (used in) operating activities:
    		                  
      changes in operating assets and liabilities, net of business acquisition
    		                  
      accounts payable - related party
    		          0 0 -132,000 0 0    
      net cash provided by, (used in) operating activities
    		                  
      cash flows from investing activities
    		                  
      cash flows from financing activities
    		                  
      principal payments on debt
    		          -10,909,000 -18,009,000 -4,368,000      
      adjustments to reconcile net income to net cash from operating activities:
    		                  
      cash flows used in (provided by) operating activities
    		                  
      adjustments to reconcile net income to net cash from (provided by) operating activities:
    		                  
      changes in operating assets and liabilities
    		                  
      cash flows used in investing activities
    		                  
      principal payments on term loan
    		                 0 
      proceeds from (payments on) revolving loan
    		                 -102,000 
      proceeds from issuance of common stock, net of underwriting discount and commissions
    		                  
      capital contribution
    		                  
      cash flows used in operating activities
    		                  
      net decrease in cash, cash equivalents and restricted cash
    		               -1,451,000 -89,308,000  
      cash, cash equivalents and restricted cash, beginning of period
    		               0 108,441,000  
      cash, cash equivalents, and restricted cash, end of period
    		               -1,451,000 19,133,000  
      changes in operating assets and liabilities:
    		                  
      internal-use software modification costs
    		                  
      proceeds from related party loan
    		                  
      debt discount and financing costs
    		                  
      proceeds from issuance of class a common stock, net of underwriting discount and commissions
    		                  
      net increase in cash, cash equivalents and restricted cash
    		                  
      cash, cash equivalents and restricted cash, beginning of year
    		                  
      cash, cash equivalents and restricted cash, end of year
    		                  
      equity based compensation
    		                  
      net decrease in cash and restricted cash
    		                  
      cash and restricted cash, beginning of year
    		                  
      cash and restricted cash, end of year
    		                  
      raw materials
    		                  
      finished goods
    		                  
      reserve for excess or obsolete inventory
    		                  
      total
    		                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.